FI950165A7 - Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön) - Google Patents

Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön) Download PDF

Info

Publication number
FI950165A7
FI950165A7 FI950165A FI950165A FI950165A7 FI 950165 A7 FI950165 A7 FI 950165A7 FI 950165 A FI950165 A FI 950165A FI 950165 A FI950165 A FI 950165A FI 950165 A7 FI950165 A7 FI 950165A7
Authority
FI
Finland
Prior art keywords
estradiol
anhydrous
beta
active ingredient
system containing
Prior art date
Application number
FI950165A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI950165L (fi
FI950165A0 (fi
Inventor
Michael Horstmann
Marion Kursawe
Horst Dzekan
Original Assignee
Lts Lohmann Therapie Systeme Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie Systeme Gmbh filed Critical Lts Lohmann Therapie Systeme Gmbh
Publication of FI950165L publication Critical patent/FI950165L/fi
Publication of FI950165A0 publication Critical patent/FI950165A0/fi
Publication of FI950165A7 publication Critical patent/FI950165A7/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
FI950165A 1992-07-16 1993-07-07 Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön) FI950165A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4223360A DE4223360C1 (enExample) 1992-07-16 1992-07-16
PCT/EP1993/001754 WO1994002151A1 (de) 1992-07-16 1993-07-07 TRANSDERMALES THERAPEUTISCHES SYSTEM MIT DEM WIRKSTOFF 17-β-ESTRADIOL (WASSERFREI)

Publications (3)

Publication Number Publication Date
FI950165L FI950165L (fi) 1995-01-13
FI950165A0 FI950165A0 (fi) 1995-01-13
FI950165A7 true FI950165A7 (fi) 1995-01-13

Family

ID=6463319

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950165A FI950165A7 (fi) 1992-07-16 1993-07-07 Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön)

Country Status (24)

Country Link
US (1) US5997897A (enExample)
EP (1) EP0650359B1 (enExample)
JP (1) JP3227577B2 (enExample)
KR (1) KR100281235B1 (enExample)
AT (1) ATE179328T1 (enExample)
AU (1) AU679450B2 (enExample)
CA (1) CA2139929C (enExample)
CZ (1) CZ283501B6 (enExample)
DE (2) DE4223360C1 (enExample)
DK (1) DK0650359T3 (enExample)
ES (1) ES2133405T3 (enExample)
FI (1) FI950165A7 (enExample)
GR (1) GR3030807T3 (enExample)
HR (1) HRP930991B1 (enExample)
HU (1) HU221011B1 (enExample)
IL (1) IL106315A (enExample)
MY (1) MY111688A (enExample)
NO (1) NO306378B1 (enExample)
NZ (1) NZ254107A (enExample)
PL (1) PL172466B1 (enExample)
SI (1) SI9300387B (enExample)
SK (1) SK280081B6 (enExample)
WO (1) WO1994002151A1 (enExample)
ZA (1) ZA935107B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1043731C (zh) * 1993-03-05 1999-06-23 中国人民解放军空军南京医院 治疗高血压的尼群地平贴片及其制备方法
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4400770C1 (de) * 1994-01-13 1995-02-02 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster zur Abgabe von Estradiol mit mindestens einem Penetrationsverstärker, Verfahren zu seiner Herstellung und seine Verwendung
DE4429664C2 (de) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
ES2162124T3 (es) * 1995-12-01 2001-12-16 Alza Corp Metodo mejorado para evitar la formacion de cristales en una dispersion de un liquido en una matriz.
US6238700B1 (en) 1995-12-01 2001-05-29 Alza Corporation Method for preventing crystal formation in a dispersion of a liquid in a matrix
DE19600347A1 (de) * 1996-01-08 1997-07-10 Lohmann Therapie Syst Lts Hauthaftende pharmazeutische Zubereitung, insbesondere TTS zur Abgabe von 17-beta-Estradiol an den menschlichen Organismus
DE19738856C2 (de) * 1997-09-05 2001-06-13 Lohmann Therapie Syst Lts Treibmittelfreies Verfahren zur Herstellung flächenförmiger Polymerschäume
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
AU760404B2 (en) * 2000-07-14 2003-05-15 Alchemia Oncology Pty Limited Hyaluronan as a cytotoxic agent, drug pre-sensitizer and chemo-sensitizer in the treatment of disease
AR033748A1 (es) * 2002-05-15 2004-01-07 Thalas Group Inc Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
US20060127463A1 (en) * 2004-12-15 2006-06-15 Nugara Peter N Composite structure including a low vinyl acetate layer
MX352283B (es) 2012-11-26 2017-11-03 Ocv Intellectual Capital Llc Tejidos multiaxiales, laminados de fibra de polímero, y cuerpos que incorporan los mismos para aplicaciones de conexión.
PL236889B1 (pl) * 2017-10-03 2021-02-22 Univ Warszawski Medyczny Nowa forma krystaliczna bezwodnego 17-β-estradiolu, sposób jej otrzymywania oraz kompozycja farmaceutyczna zawierająca nową formę krystaliczną bezwodnego 17-β-estradiolu i jej zastosowanie
HUP2200237A2 (hu) * 2022-06-27 2023-12-28 Pecsi Tudomanyegyetem Alacsony dózisú, stabil hatóanyag-leadású transzdermális készítmény és tapasz, valamint eljárás ezek elõállítására

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
US4832953A (en) * 1987-08-13 1989-05-23 Alza Corporation Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
US4863738A (en) * 1987-11-23 1989-09-05 Alza Corporation Skin permeation enhancer compositions using glycerol monooleate
JP2681365B2 (ja) * 1988-04-11 1997-11-26 日東電工株式会社 経皮吸収性製剤及びその製法
JPH0279792A (ja) * 1988-09-12 1990-03-20 Secoh Giken Inc 高速３相直流電動機
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster

Also Published As

Publication number Publication date
EP0650359A1 (de) 1995-05-03
IL106315A0 (en) 1993-11-15
KR950702423A (ko) 1995-07-29
NO950047D0 (no) 1995-01-05
MY111688A (en) 2000-11-30
HRP930991B1 (en) 2000-02-29
ES2133405T3 (es) 1999-09-16
HUT70161A (en) 1995-09-28
DE59309549D1 (de) 1999-06-02
IL106315A (en) 1998-07-15
CA2139929A1 (en) 1994-02-03
SK280081B6 (sk) 1999-07-12
AU4565093A (en) 1994-02-14
PL172466B1 (pl) 1997-09-30
ZA935107B (en) 1994-02-04
FI950165L (fi) 1995-01-13
DK0650359T3 (da) 1999-11-08
DE4223360C1 (enExample) 1993-04-08
KR100281235B1 (ko) 2001-02-01
CA2139929C (en) 2004-10-19
AU679450B2 (en) 1997-07-03
FI950165A0 (fi) 1995-01-13
ATE179328T1 (de) 1999-05-15
WO1994002151A1 (de) 1994-02-03
CZ283501B6 (cs) 1998-04-15
NO950047L (no) 1995-01-05
CZ10695A3 (en) 1995-09-13
SK146894A3 (en) 1996-01-10
HU221011B1 (hu) 2002-07-29
JPH07508991A (ja) 1995-10-05
SI9300387A (en) 1994-03-31
HU9403474D0 (en) 1995-02-28
HRP930991A2 (en) 1995-02-28
GR3030807T3 (en) 1999-11-30
EP0650359B1 (de) 1999-04-28
US5997897A (en) 1999-12-07
NO306378B1 (no) 1999-11-01
SI9300387B (sl) 2002-02-28
JP3227577B2 (ja) 2001-11-12
NZ254107A (en) 1996-03-26

Similar Documents

Publication Publication Date Title
FI953533L (fi) Transdermaalinen terapeuttinen järjestelmä, jossa on galantamiinia vaikuttavana aineena
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
FI950165A7 (fi) Ihon läpäisevä terapeuttinen järjestelmä, jossa vaikuttavana aineena o n 17-beta-estradioli (vedetön)
FI960556L (fi) Transdermaalinen aktiivisten lääkeaineiden hitaan virtauksen antojärjestelmä
NO933854D0 (no) Promedikamenter, deres fremstilling og anvendelse som legemiddel
DE69113205D1 (de) Transdermales therapeutisches System.
FI954990L (fi) Aktiiviainetta sisältävä transdermaalinen valmiste
NO952269D0 (no) Stabiliserte medisinske aerosollösnings-formuleringer
FI932695A7 (fi) Angiotensiini I kymaasi(e)n inhibiittoreita, mukaanlukien ihmisen sydänkymaasin
ITTV920120A0 (it) Struttura di dispositivo di frenata, particolarmente per pattini
FI972542L (fi) Transdermaalijärjestelmä useamman aktiivisen aineen samanaikaista antamista varten
FI961437L (fi) Vaikuttavan aineen luovuttava systeemi
DE69007592D1 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
BR9607560A (pt) Composições cométicas anidras contendo agentes dermatologicamente ativo
FI961435L (fi) Transdermaalinen terapeuttinen järjestelmä joka sisältää oktyylidodekanolia kiteytymisen inhibiittoreina
FI875098A7 (fi) Transdermaalinen terapeuttinen systeemi.
NL192304B (nl) Noötropisch geneesmiddel dat als werkzaam bestanddeel een pyroglutaminezuuramidederivaat bevat en een dergelijk pyroglutaminezuuramidederivaat.
FI962220L (fi) Transdermaalinen terapeuttinen järjestelmä
FI962550L (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
KR950700743A (ko) 프로스타사이클린류를 활성성분으로서 함유하는 외용 피부치료제 조성물(dermatologic preparation composition containing prostacyclin as active ingredient)
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
KR970000225A (ko) 시네프린을 유효성분으로 함유하는 우울증 치료제
IT229255Y1 (it) Struttura di dipositivo di frenatura, particolarmente per pattini